Living with fibromyalgia often means anticipating symptoms that shift from one day to the next. A proven solution backed by steady, workable support can make a meaningful and measurable difference.
A more manageable rhythm for handling those day-to-day changes starts with Microdose Therapy™. Microdose Therapy™ is a safe, self-guided way to control symptoms with more confidence and less uncertainty, while providing chronic pain relief that fits naturally into daily routines.
Inside Cortisol and Microdose Therapy™
Cortisol is a naturally-occurring hormone that helps keep inflammation and stress in check. When something hurts or your body feels strained, cortisol levels rise to help calm things down. As your body settles, those levels return to normal.
In cortisol-responding diseases like fibromyalgia, these natural signals may not work as well as they should. That’s why symptoms can come and go so unpredictably. Microdose Therapy™ uses low doses of cortisone, carefully timed, to give the body a little extra support on the days when it’s needed most. Because the doses stay below what the body naturally produces, patients remain safely under the threshold linked to common cortisol related side effects.
Microdose Therapy™ takes this gentle, steady approach by using only a small dose on days when symptoms rise—and none on the good days.
A Supportive Approach Designed for Everyday Life
Microdose Therapy™ is shaped by decades of clinical work exploring how dosage and timing of cortisone help ease symptoms in cortisol-responding diseases, including fibromyalgia. One large 2019 study involving 2,015 individuals reported an average symptom improvement of 76%, with people with fibromyalgia experiencing about 77% improvement.¹
An earlier clinical trial also showed that small, well-timed doses of cortisone helped people, supporting the value of microdosing for pain in carefully-monitored settings.2 Further studies examined how people could follow this same method, highlighting the value of safe-use limits and guided self-administered medication regimens.3 This foundational research helped form the steady, supportive approach used in Microdose Therapy™ today.
Microdose Therapy™ guides patients in self-administering cortisone under the safe use limit, treating using cortisone on days when symptoms arise and none on the good days. This method follows the rhythm of symptoms, offering support when it’s needed most.
In our program, patients receive medication guidance, daily symptom tracking, coaching and support. Our proprietary online Relief Radar portal is woven into this process as an easy, day-to-day tool that helps patients manage their symptoms over time. The combination of tracking and guidance, unique to Microdose Therapy™ enables you to stay within safe limits.
Making Your Days More Manageable
Fibromyalgia symptoms can be hard to plan around, and steady support combined with a proven solution can make life feel far more manageable. Microdose Therapy™ meets you where you are, working with the natural rhythm of your symptoms rather than against them.
If you’d like to explore how Microdose Therapy™ can provide chronic pain relief for your fibromyalgia symptoms, we’re here to help. Reach out anytime—we’re always happy to answer questions, offer guidance, and help you move toward days that feel easier to manage.
Sources
- Irwin JB, Baldwin AL, Stenberg VI. General theory of inflammation: patient self-administration of hydrocortisone safely achieves superior control of hydrocortisone-responding disorders by matching dosage with symptom intensity. J Inflamm Res. 2019;12:161-166 https://doi.org/10.2147/JIR.S195165
- Stenberg VI, Fiechtner JJ, Rice JR, Miller DR, Johnson LK. Endocrine control of inflammation: rheumatoid arthritis double-blind, crossover clinical trial. International Journal of Clinical Pharmacology Research. 1992 ;12(1):11-18. PMID: 1526694. https://europepmc.org/article/med/1526694
- Stenberg, Virgil, and Ann L. Baldwin. 2023. ‘Safe Use of Cortisol for Inflammation Disorders’. Updates on Corticosteroids. IntechOpen. doi:10.5772/intechopen.110115. https://www.intechopen.com/chapters/86479